www.empr.com Open in urlscan Pro
2606:4700::6812:19e4  Public Scan

Submitted URL: http://links.hcpconnects10.com/els/v2/jbZ~hLKqj3tV/TUI3MkZ0YkVWcXlpeFFZNGNNcFhtdGRtYng5MERpdDR3NTFPV2QrVThPL0JNcWMvQXZoK0xyck12...
Effective URL: https://www.empr.com/home/news/quviviq-now-available-for-adults-with-insomnia/
Submission: On May 17 via api from US — Scanned from DE

Form analysis 3 forms found in the DOM

https://www.empr.com/

<form class="search focus-label" id="mobile-search" aria-hidden="false" action="https://www.empr.com/">
  <input class="searchinput predictive-search" id="q" type="text" value="" name="s">
  <label class="searchformlabel " id="q-label" for="q"> Search drug information, news and resources </label>
  <button class="submit" type="submit">
    <span class="searchicon">
      <svg role="presentation" class="icon icon--search" aria-label="search">
        <use xlink:href="https://www.empr.com/wp-content/themes/haymarket/assets/svg/src.svg?ver=1647459195#search"></use>
      </svg> </span>
    <span class="screen-reader-text">Submit</span>
  </button>
</form>

<form class="HMIRegistration__form" novalidate="">
  <div class="HMIRegistration__row ">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__form-control HMIRegistration__input "><input class="form-control" type="email" id="root_subscriber_email" label="email" placeholder="*E-mail Address" value="">
        <div></div>
      </div>
    </div>
  </div>
  <div class="HMIRegistration__row ">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__form-control "><select class="HMIRegistration__select">
          <option value="">*Select a Country</option>
          <option value="AF">Afghanistan</option>
          <option value="AL">Albania</option>
          <option value="DZ">Algeria</option>
          <option value="AS">American Samoa</option>
          <option value="AD">Andorra</option>
          <option value="AO">Angola</option>
          <option value="AI">Anguilla</option>
          <option value="AQ">Antarctica</option>
          <option value="AG">Antigua and Barbuda</option>
          <option value="AR">Argentina</option>
          <option value="AM">Armenia</option>
          <option value="AW">Aruba</option>
          <option value="AU">Australia</option>
          <option value="AT">Austria</option>
          <option value="AZ">Azerbaijan</option>
          <option value="BS">Bahamas</option>
          <option value="BH">Bahrain</option>
          <option value="BD">Bangladesh</option>
          <option value="BB">Barbados</option>
          <option value="BY">Belarus</option>
          <option value="BE">Belgium</option>
          <option value="BZ">Belize</option>
          <option value="BJ">Benin</option>
          <option value="BM">Bermuda</option>
          <option value="BT">Bhutan</option>
          <option value="BO">Bolivia</option>
          <option value="BA">Bosnia and Herzegovina</option>
          <option value="BW">Botswana</option>
          <option value="BV">Bouvet Island</option>
          <option value="BR">Brazil</option>
          <option value="IO">British Indian Ocean Territory</option>
          <option value="BN">Brunei Darussalam</option>
          <option value="BG">Bulgaria</option>
          <option value="BF">Burkina Faso</option>
          <option value="BI">Burundi</option>
          <option value="KH">Cambodia</option>
          <option value="CM">Cameroon</option>
          <option value="CA">Canada</option>
          <option value="CV">Cape Verde</option>
          <option value="KY">Cayman Islands</option>
          <option value="CF">Central African Republic</option>
          <option value="TD">Chad</option>
          <option value="CL">Chile</option>
          <option value="CN">China</option>
          <option value="CX">Christmas Island</option>
          <option value="CC">Cocos (Keeling) Islands</option>
          <option value="CO">Colombia</option>
          <option value="KM">Comoros</option>
          <option value="CG">Congo</option>
          <option value="CD">Congo (DRC)</option>
          <option value="CK">Cook Islands</option>
          <option value="CR">Costa Rica</option>
          <option value="HR">Croatia</option>
          <option value="CU">Cuba</option>
          <option value="CY">Cyprus</option>
          <option value="CZ">Czech Republic</option>
          <option value="CI">Côte D'Ivoire</option>
          <option value="DK">Denmark</option>
          <option value="DJ">Djibouti</option>
          <option value="DM">Dominica</option>
          <option value="DO">Dominican Republic</option>
          <option value="EC">Ecuador</option>
          <option value="EG">Egypt</option>
          <option value="SV">El Salvador</option>
          <option value="GQ">Equatorial Guinea</option>
          <option value="ER">Eritrea</option>
          <option value="EE">Estonia</option>
          <option value="ET">Ethiopia</option>
          <option value="FK">Falkland Islands (Malvinas)</option>
          <option value="FO">Faroe Islands</option>
          <option value="FJ">Fiji Islands</option>
          <option value="FI">Finland</option>
          <option value="FR">France</option>
          <option value="GF">French Guiana</option>
          <option value="PF">French Polynesia</option>
          <option value="TF">French Southern Territories</option>
          <option value="GA">Gabon</option>
          <option value="GM">Gambia</option>
          <option value="GE">Georgia</option>
          <option value="DE">Germany</option>
          <option value="GH">Ghana</option>
          <option value="GI">Gibraltar</option>
          <option value="GR">Greece</option>
          <option value="GL">Greenland</option>
          <option value="GD">Grenada</option>
          <option value="GP">Guadeloupe</option>
          <option value="GU">Guam</option>
          <option value="GT">Guatemala</option>
          <option value="GN">Guinea</option>
          <option value="GW">Guinea-Bissau</option>
          <option value="GY">Guyana</option>
          <option value="HT">Haiti</option>
          <option value="HM">Heard Island and Mcdonald Islands</option>
          <option value="HN">Honduras</option>
          <option value="HK">Hong Kong</option>
          <option value="HU">Hungary</option>
          <option value="IS">Iceland</option>
          <option value="IN">India</option>
          <option value="ID">Indonesia</option>
          <option value="IR">Iran</option>
          <option value="IQ">Iraq</option>
          <option value="IE">Ireland</option>
          <option value="IL">Israel</option>
          <option value="IT">Italy</option>
          <option value="JM">Jamaica</option>
          <option value="JP">Japan</option>
          <option value="JO">Jordan</option>
          <option value="KZ">Kazakhstan</option>
          <option value="KE">Kenya</option>
          <option value="KI">Kiribati</option>
          <option value="KR">Korea</option>
          <option value="KW">Kuwait</option>
          <option value="KG">Kyrgyzstan</option>
          <option value="LA">Laos</option>
          <option value="LV">Latvia</option>
          <option value="LB">Lebanon</option>
          <option value="LS">Lesotho</option>
          <option value="LR">Liberia</option>
          <option value="LY">Libya</option>
          <option value="LI">Liechtenstein</option>
          <option value="LT">Lithuania</option>
          <option value="LU">Luxembourg</option>
          <option value="MO">Macao</option>
          <option value="MK">Macedonia</option>
          <option value="MG">Madagascar</option>
          <option value="MW">Malawi</option>
          <option value="MY">Malaysia</option>
          <option value="MV">Maldives</option>
          <option value="ML">Mali</option>
          <option value="MT">Malta</option>
          <option value="MH">Marshall Islands</option>
          <option value="MQ">Martinique</option>
          <option value="MR">Mauritania</option>
          <option value="MU">Mauritius</option>
          <option value="YT">Mayotte</option>
          <option value="MX">Mexico</option>
          <option value="FM">Micronesia</option>
          <option value="MD">Moldova</option>
          <option value="MC">Monaco</option>
          <option value="MN">Mongolia</option>
          <option value="ME">Montenegro</option>
          <option value="MS">Montserrat</option>
          <option value="MA">Morocco</option>
          <option value="MZ">Mozambique</option>
          <option value="MM">Myanmar</option>
          <option value="NA">Namibia</option>
          <option value="NR">Nauru</option>
          <option value="NP">Nepal</option>
          <option value="NL">Netherlands</option>
          <option value="AN">Netherlands Antilles</option>
          <option value="NC">New Caledonia</option>
          <option value="NZ">New Zealand</option>
          <option value="NI">Nicaragua</option>
          <option value="NE">Niger</option>
          <option value="NG">Nigeria</option>
          <option value="NU">Niue</option>
          <option value="NF">Norfolk Island</option>
          <option value="KP">North Korea</option>
          <option value="MP">Northern Mariana Islands</option>
          <option value="NO">Norway</option>
          <option value="OM">Oman</option>
          <option value="PK">Pakistan</option>
          <option value="PW">Palau</option>
          <option value="PA">Panama</option>
          <option value="PG">Papua New Guinea</option>
          <option value="PY">Paraguay</option>
          <option value="PE">Peru</option>
          <option value="PH">Philippines</option>
          <option value="PN">Pitcairn</option>
          <option value="PL">Poland</option>
          <option value="PT">Portugal</option>
          <option value="PR">Puerto Rico</option>
          <option value="QA">Qatar</option>
          <option value="RE">Reunion</option>
          <option value="RO">Romania</option>
          <option value="RU">Russia</option>
          <option value="RW">Rwanda</option>
          <option value="SH">Saint Helena</option>
          <option value="KN">Saint Kitts and Nevis</option>
          <option value="LC">Saint Lucia</option>
          <option value="MF">Saint Martin</option>
          <option value="PM">Saint Pierre and Miquelon</option>
          <option value="VC">Saint Vincent and The Grenadines</option>
          <option value="SM">San Marino</option>
          <option value="ST">Sao Tome &amp; Principe</option>
          <option value="SA">Saudi Arabia</option>
          <option value="SN">Senegal</option>
          <option value="YU">Serbia and Montenegro</option>
          <option value="RS">Serbia-Montenegro</option>
          <option value="SC">Seychelles</option>
          <option value="SL">Sierra Leone</option>
          <option value="SG">Singapore</option>
          <option value="SK">Slovakia</option>
          <option value="SI">Slovenia</option>
          <option value="SB">Solomon Islands</option>
          <option value="SO">Somalia</option>
          <option value="ZA">South Africa</option>
          <option value="ES">Spain</option>
          <option value="LK">Sri Lanka</option>
          <option value="SD">Sudan</option>
          <option value="SR">Suriname</option>
          <option value="SJ">Svalbard and Jan Mayen</option>
          <option value="SZ">Swaziland</option>
          <option value="SE">Sweden</option>
          <option value="CH">Switzerland</option>
          <option value="SY">Syria</option>
          <option value="TW">Taiwan</option>
          <option value="TJ">Tajikistan</option>
          <option value="TZ">Tanzania</option>
          <option value="TH">Thailand</option>
          <option value="TP">Timor-Leste</option>
          <option value="TG">Togo</option>
          <option value="TK">Tokelau</option>
          <option value="TO">Tonga</option>
          <option value="TT">Trinidad and Tobago</option>
          <option value="TN">Tunisia</option>
          <option value="TR">Turkey</option>
          <option value="TM">Turkmenistan</option>
          <option value="TC">Turks and Caicos Islands</option>
          <option value="TV">Tuvalu</option>
          <option value="UG">Uganda</option>
          <option value="UA">Ukraine</option>
          <option value="AE">United Arab Emirates</option>
          <option value="UK">United Kingdom</option>
          <option value="US">United States</option>
          <option value="UY">Uruguay</option>
          <option value="UZ">Uzbekistan</option>
          <option value="VU">Vanuatu</option>
          <option value="VA">Vatican City</option>
          <option value="VE">Venezuela</option>
          <option value="VN">Viet Nam</option>
          <option value="VI">Virgin Islands</option>
          <option value="VG">Virgin Islands, British</option>
          <option value="WF">Wallis and Futuna</option>
          <option value="WS">Western Samoa</option>
          <option value="YE">Yemen</option>
          <option value="ZM">Zambia</option>
          <option value="ZW">Zimbabwe</option>
        </select>
        <div class="HMIRegistration__select--down-caret"><svg width="14 " height="12" class="widget-svg">
            <polygon class="down-caret" points="7 12, 14 0, 0 0"></polygon>
          </svg></div>
        <div></div>
      </div>
    </div>
  </div>
  <div class="HMIRegistration__row ">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__form-control--checkbox ">
        <div class="HMIRegistration__checkbox"><span class="HMIRegistration__sprite ismedical"><span class="HMIRegistration__sprite-border "></span><span class="HMIRegistration__sprite-checkmark "><svg width="15" height="15" class="widget-svg">
                <path class="checkmark" d="M5.6,13.4C3.7,11.6,1.9,9.8,0,8c0.8-0.8,1.6-1.6,2.3-2.3c1.1,1,2.2,2.1,3.3,3.1c2.4-2.4,4.7-4.8,7-7.2 c0.8,0.8,1.5,1.6,2.3,2.3C11.9,7,8.8,10.2,5.6,13.4z"></path>
              </svg></span><span class="HMIRegistration__sprite-fill "></span></span><span class="HMIRegistration__text ">Expertscape</span></div>
      </div>
      <div class="HMIRegistration__form-control--checkbox ">
        <div class="HMIRegistration__checkbox"><span class="HMIRegistration__sprite ismedical"><span class="HMIRegistration__sprite-border u-active"></span><span class="HMIRegistration__sprite-checkmark u-active"><svg width="15" height="15"
                class="widget-svg">
                <path class="checkmark" d="M5.6,13.4C3.7,11.6,1.9,9.8,0,8c0.8-0.8,1.6-1.6,2.3-2.3c1.1,1,2.2,2.1,3.3,3.1c2.4-2.4,4.7-4.8,7-7.2 c0.8,0.8,1.5,1.6,2.3,2.3C11.9,7,8.8,10.2,5.6,13.4z"></path>
              </svg></span><span class="HMIRegistration__sprite-fill u-active"></span></span><span class="HMIRegistration__text u-active">Coronavirus Briefing</span></div>
      </div>
      <div class="HMIRegistration__form-control--checkbox ">
        <div class="HMIRegistration__checkbox"><span class="HMIRegistration__sprite ismedical"><span class="HMIRegistration__sprite-border u-active"></span><span class="HMIRegistration__sprite-checkmark u-active"><svg width="15" height="15"
                class="widget-svg">
                <path class="checkmark" d="M5.6,13.4C3.7,11.6,1.9,9.8,0,8c0.8-0.8,1.6-1.6,2.3-2.3c1.1,1,2.2,2.1,3.3,3.1c2.4-2.4,4.7-4.8,7-7.2 c0.8,0.8,1.5,1.6,2.3,2.3C11.9,7,8.8,10.2,5.6,13.4z"></path>
              </svg></span><span class="HMIRegistration__sprite-fill u-active"></span></span><span class="HMIRegistration__text u-active">MPR Daily Dose</span></div>
      </div>
    </div>
  </div>
  <div class="HMIRegistration__row HMIRegistration__opt-in-email" style="display: none;">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__checkbox"><span class="HMIRegistration__sprite"><span class="HMIRegistration__sprite-border "></span><span class="HMIRegistration__sprite-checkmark "><svg width="15" height="15" class="widget-svg">
              <path class="checkmark" d="M5.6,13.4C3.7,11.6,1.9,9.8,0,8c0.8-0.8,1.6-1.6,2.3-2.3c1.1,1,2.2,2.1,3.3,3.1c2.4-2.4,4.7-4.8,7-7.2 c0.8,0.8,1.5,1.6,2.3,2.3C11.9,7,8.8,10.2,5.6,13.4z"></path>
            </svg></span><span class="HMIRegistration__sprite-fill "></span></span><span class="HMIRegistration__text ">I would like to receive relevant information via email from MPR / Haymarket Medical Network.</span></div>
    </div>
  </div>
  <div class="HMIRegistration__row HMIRegistration__opt-in-email" style="display: none;">
    <div class="HMIRegistration__column u-col12">By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as described in our
      <a href="/privacypolicy" target="_blank">privacy policy</a> and &nbsp;<a href="/termsandconditions" target="_blank">terms and conditions</a></div>
  </div><button class="HMIRegistration__submit" type="submit">Submit</button>
  <div class="HMIRegistration__us_privacy-policy privacy__terms" id="newsletter-asset" style="display: block;"><a href="https://www.haymarketmediaus.com/haymarket-media-medical-privacy-policy/" target="_blank">Privacy Policy</a> &nbsp;|
    &nbsp;<a href="https://www.haymarketmediaus.com/haymarket-medical-business-terms-conditions/" target="_blank">Terms &amp; Conditions</a></div>
</form>

<form class="HMIRegistration__form ismedical" novalidate="">
  <div class="HMIRegistration__row ">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__form-control HMIRegistration__input "><input class="form-control" type="email" id="root_email" label="email" placeholder="*E-mail Address" value="">
        <div></div>
      </div>
    </div>
  </div>
  <div class="HMIRegistration__row ">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__form-control HMIRegistration__input "><input class="form-control" type="password" id="root_password" label="password" placeholder="*Password" value="">
        <div></div>
      </div>
    </div>
  </div>
  <div class="HMIRegistration__row ">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__checkbox"><span class="HMIRegistration__sprite"><span class="HMIRegistration__sprite-border "></span><span class="HMIRegistration__sprite-checkmark "><svg width="15" height="15" class="widget-svg">
              <path class="checkmark" d="M5.6,13.4C3.7,11.6,1.9,9.8,0,8c0.8-0.8,1.6-1.6,2.3-2.3c1.1,1,2.2,2.1,3.3,3.1c2.4-2.4,4.7-4.8,7-7.2 c0.8,0.8,1.5,1.6,2.3,2.3C11.9,7,8.8,10.2,5.6,13.4z"></path>
            </svg></span><span class="HMIRegistration__sprite-fill "></span></span><span class="HMIRegistration__text ">Keep me signed in</span></div>
    </div>
  </div>
  <p class="HMIRegistration__text linkToForgetPword ismedical"><a href="#" class="HMIRegistration__link ismedical">Forgot your password?</a></p><button class="HMIRegistration__submit ismedical" type="submit">Login</button>
  <p class="HMIRegistration__text goToRegister ismedical"><a href="#" class="HMIRegistration__link ismedical">Do not have an account yet?<strong> Register</strong></a></p>
</form>

Text Content

Skip to navigation Skip to main content
 * Subscribe

Login Register
 * 
 * 
 * 

Menu Close
 * Resource CentersOpen Submenu
   * Resource Centers Back
      * Allergic Disorders
      * Cardiovascular Disease
      * Dermatological Disorders
      * Diagnostic Agents
      * Endocrine Disorders
      * Gastrohepatic Disorders
     
      * Geriatrics
      * Hematological Disorders
      * Immune Disorders
      * Immunization
      * Infectious Diseases
      * Kidney Disease
      * Metabolic Disorders
     
      * Musculoskeletal Disorders
      * Neurologic Disorders
      * Nutrition
      * OB/GYN
      * Oncology
      * Ophthalmic Disorders
     
      * Oral Health
      * Otic Disorders
      * Pain Management
      * Pediatrics
      * Poisoning & Drug Dependence
      * Psychiatric Disorders
      * Respiratory Disorders
      * Urological Disorders
 * DrugsOpen Submenu
   * Drugs Back
     
     DRUG SEARCH
     
      * Browse by Brand
      * Browse by Generic
      * Browse by Therapeutic Category
      * Browse by Manufacturer
     
     MORE
     
      * New Drug Products
      * Drug Monograph Updates
      * Drug Treatment Tables
     
     NEW DRUG PRODUCTS
     
      * New Drug Product: Susvimo
      * New Drug Product: Xywav
      * New Drug Product: Wegovy
 * NewsOpen Submenu
   * News Back
      * Drug News
      * Alternative Medicine
      * Safety Alerts and Recalls
      * Generics News
      * Drugs in the Pipeline
     
      * The Weekly Dose Podcast
      * Conference Coverage
      * Guidelines
      * Medical Technology
      * Healthcare Policy
 * FeaturesOpen Submenu
   * Features Back
      * Features
      * Case Studies
      * Expert Perspective
      * How I Treat
      * Clinician POV
      * Drug Primer
     
     LATEST FEATURES
     
      * Court Rules That State’s Medical Malpractice Act Can Apply to
        Nonpatients
      * Interview With Dr Tobias Janowitz on Conducting Fully Remote Trials
      * Interview with Dr Preeti N. Malani, Chief Health Officer at the
        University of Michigan
     
     MY DIAGNOSIS IS...
     
      * Clinical Challenge: Facial Growth in Older Man With Sun Damage
      * Clinical Challenge: Raised Lesion on Back
      * Clinical Challenge: Expanding Raised Rash
 * Charts
 * ToolsOpen Submenu
   * Tools Back
     
     EXPAND YOUR KNOWLEDGE
     
      * Calculators
      * ICD-10
      * Patient Information
      * Industry Supported Education
     
     ENRICH YOUR PRACTICE
     
      * CME Courses
      * Jobs
     
     HAVE A LITTLE FUN!
     
      * Cartoons
      * Quizzes
 * CME/CE
 * App

Search drug information, news and resources Submit
Advertisement



Home » News

Publish Date May 3, 2022


QUVIVIQ NOW AVAILABLE FOR ADULTS WITH INSOMNIA

Brian Park, PharmD

 * Share on Facebook
 * Share on Twitter
 * Share on LinkedIn
 * Share on Reddit
 * Print
 * Share by Email

Quviviq is classified as a Schedule IV controlled substance. Credit: Idorsia.


Quviviq (daridorexant) is now available for the treatment of adults with
insomnia characterized by difficulties with sleep onset and/or sleep
maintenance.

Quviviq contains daridorexant, an orexin receptor antagonist. Approval was based
on data from a comprehensive development program that included two phase 3
studies (ClinicalTrials.gov Identifier: NCT03545191 [Study 1] and NCT03575104
[Study 2]). The double-blind studies compared the efficacy and safety of
daridorexant to placebo in 1854 patients 18 years of age and older with insomnia
for 3 months. 

Findings from Study 1 and Study 2 showed that daridorexant demonstrated
statistically significant and clinically meaningful improvements in sleep onset,
sleep maintenance, and patient reported total sleep time. Patients treated with
daridorexant also had a significant reduction in daytime sleepiness, as assessed
by a validated sleep diary questionnaire.

The most common adverse reactions reported were headache and somnolence or
fatigue.  Daridorexant was not associated with next morning residual effects,
rebound insomnia, or withdrawal symptoms upon discontinuation.

As with other hypnotics, there is a risk of CNS depressant effects, worsening of
depression or suicidal ideation, sleep paralysis, hypnagogic/hypnopompic
hallucinations, cataplexy-like symptoms, and complex sleep behaviors. Quviviq is
contraindicated in patients with narcolepsy. Additionally, the treatment has not
been studied in patients with moderate obstructive sleep apnea (OSA) requiring
CPAP, severe OSA, or severe COPD; the effects of Quviviq on respiratory function
should be considered if prescribed to patients with compromised respiratory
function.

Quviviq tablets are available in 2 dosage strengths: 25mg and 50mg.
Coadministration with strong CYP3A4 inhibitors or with strong or moderate CYP3A4
inducers should be avoided. Patients taking moderate CYP3A4 inhibitors or those
with moderate hepatic impairment should not take more than 25mg once per night.
Quviviq is not recommended for patients with severe hepatic impairment.

Treatment should be administered within 30 minutes of going to bed, with at
least 7 hours remaining prior to planned awakening, as the risk of daytime
impairment is increased if the drug is taken with less than a full night of
sleep remaining. Time to sleep onset may be delayed if Quviviq is take with or
soon after a meal.

References

 1. Idorsia’s new treatment Quviviq (daridorexant) is now available in the US
    for adults living with insomnia. News release. Idorsia Pharmaceuticals Ltd.
    Accessed May 2, 2022.
    https://www.globenewswire.com/news-release/2022/05/02/2433104/0/en/Idorsia-s-new-treatment-QUVIVIQ-daridorexant-is-now-available-in-the-US-for-adults-living-with-insomnia.html
 2. Quviviq. Package insert. Idorsia Pharmaceuticals Ltd; 2021. Accessed January
    10, 2022. https://www.idorsia.us/documents/us/label/Quviviq_PI.pdf


TOPICS:

General Psychiatry Insomnia Sleep Disorders


 * GET MPR IN YOUR INBOX
   
   Sign up to get the latest MPR news in your inbox.
   
   *Select a CountryAfghanistanAlbaniaAlgeriaAmerican
   SamoaAndorraAngolaAnguillaAntarcticaAntigua and
   BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia
   and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean
   TerritoryBrunei DarussalamBulgariaBurkina
   FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African
   RepublicChadChileChinaChristmas IslandCocos (Keeling)
   IslandsColombiaComorosCongoCongo (DRC)Cook IslandsCosta
   RicaCroatiaCubaCyprusCzech RepublicCôte
   D'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl
   SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland Islands
   (Malvinas)Faroe IslandsFiji IslandsFinlandFranceFrench GuianaFrench
   PolynesiaFrench Southern
   TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuineaGuinea-BissauGuyanaHaitiHeard
   Island and Mcdonald IslandsHondurasHong
   KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyJamaicaJapanJordanKazakhstanKenyaKiribatiKoreaKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall
   IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNetherlands
   AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth
   KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPanamaPapua New
   GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto
   RicoQatarReunionRomaniaRussiaRwandaSaint HelenaSaint Kitts and NevisSaint
   LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and The GrenadinesSan
   MarinoSao Tome & PrincipeSaudi ArabiaSenegalSerbia and
   MontenegroSerbia-MontenegroSeychellesSierra
   LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSpainSri
   LankaSudanSurinameSvalbard and Jan
   MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad
   and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos
   IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited
   StatesUruguayUzbekistanVanuatuVatican CityVenezuelaViet NamVirgin
   IslandsVirgin Islands, BritishWallis and FutunaWestern
   SamoaYemenZambiaZimbabwe
   
   
   Expertscape
   Coronavirus Briefing
   MPR Daily Dose
   I would like to receive relevant information via email from MPR / Haymarket
   Medical Network.
   By registering you consent to the collection and use of your information to
   provide the products and services you have requested from us and as described
   in our privacy policy and  terms and conditions
   Submit
   Privacy Policy  |  Terms & Conditions

 * Advertisement

 * 

 * Advertisement
 *  * Popular
    * Emailed
    * Recent
   
    * Serotonergic Antidepressants in Pregnancy Not Tied to Neonatal Seizures
    * April 2022: Notable Drug Approvals
    * One in 3 Alzheimer, Dementia Cases Tied to Modifiable Risk Factors
    * NIH Launches Clinical Trial of Epstein-Barr Virus Vaccine
    * Efficacy Response Maintained With Deucravacitinib in Plaque Psoriasis
      Trial
   
    * Lenacapavir Reduces Viral Load in Multidrug-Resistant HIV-1 Infection
    * Review: Power Training, Strength Training Compared for Older Adults
    * Significant Improvements in Myasthenia Gravis Seen With Zilucoplan,
      Rozanolixizumab
    * CVD Risk Not Reduced With Dual Use of E-Cigarettes, Smoking
    * CDC: Overdose Deaths Up 15% in 2021
   
    * FDA Approves First-in-Class Treatment for Type 2 Diabetes
    * Beyond Hysterectomy: Increasing Awareness of Uterine Fibroids and New
      Treatment Options
    * FDA Decision on Bimekizumab for Plaque Psoriasis Delayed
    * Oral Suspension Formulation of Edaravone Approved for ALS
    * Pirfenidone Tablets Now Available for Idiopathic Pulmonary Fibrosis

 * 


WANT TO READ MORE?

Please login or register first to view this content.

Login Register


Back to Top

 * RESOURCES
   
    * MPR Publications
    * Reprints/Licensing
    * Subscribe

 * Do Not Sell Personal Information

 * 
 * 
 * 

 * USER CENTER
   
    * FAQ
    * Customer Service
    * Advertise
    * User Feedback

 * HAYMARKET MEDICAL NETWORK
   
    * Cancer Therapy Advisor
    * Clinical Advisor
    * Clinical Pain Advisor
    * Dermatology Advisor
    * Endocrinology Advisor
    * Gastroenterology Advisor
    * Hematology Advisor
    * Infectious Disease Advisor
    * McKnight’s Long Term Care News
    * McKnight’s Senior Living

 *    
   
    * Medical Bag
    * myCME
    * Neurology Advisor
    * Oncology Nurse Advisor
    * Ophthalmology Advisor
    * Optometry Advisor
    * Psychiatry Advisor
    * Pulmonology Advisor
    * Rare Disease Advisor
    * Renal & Urology News
    * Rheumatology Advisor
    * The Cardiology Advisor

 * Copyright © 2022 Haymarket Media, Inc. All Rights Reserved
   This material may not be published, broadcast, rewritten or redistributed in
   any form without prior authorization.
   Your use of this website constitutes acceptance of Haymarket Media’s Privacy
   Policy and Terms & Conditions.

Some areas of this page may shift around if you resize the browser window. Be
sure to check heading and document order.
Close more info about Quviviq Now Available for Adults With Insomnia


LOG IN TO MPR




PLEASE LOG IN USING YOUR PASSWORD.

*Required
Keep me signed in

Forgot your password?

Login

Do not have an account yet? Register


Close more info about Quviviq Now Available for Adults With Insomnia


JOIN THE




CREATING YOUR FREE ACCOUNT WITH MPR ALLOWS YOU ACCESS TO EXCLUSIVE CONTENT,
INCLUDING CASE STUDIES, DRUG INFORMATION, CME AND MORE ACROSS OUR GROWING
NETWORK OF CLINICAL SITES.

*Required
*ProfessionCertified Diabetes EducatorClinical Nurse SpecialistConsumer /
PatientDentistDietitian / NutritionistGenetic CounselorNurseNurse
PractitionerOther Healthcare ProfessionalPharmacistPhysicianPhysician
AssistantPsychologistResidentStudent

*SpecialtyAllergy / ImmunologyAnesthesiologyBariatric
MedicineCardiologyComplementary / Alternative MedicineCritical Care
MedicineDentalDermatologyDiabetesEmergency MedicineEndocrinologyFamily Medicine
/ General PracticeGastroenterology / ProctologyGeriatric
MedicineHematologyHematology / OncologyHospitalistInfectious DiseaseInfusion
TherapyInternal MedicineLong-Term CareNephrologyNeurologyNutritionObstetrics /
GynecologyOncologyOphthalmologyOptometryOrthopedicsOtolaryngologyPain
MedicinePathologyPediatricsPharmacyPhysical Medicine /
RehabilitationPsychiatryPublic Health / Preventive MedicinePulmonologyRadiology
/ Nuclear MedicineRheumatologySports MedicineSurgeryUrologyOther

*Select a CountryAfghanistanAlbaniaAlgeriaAmerican
SamoaAndorraAngolaAnguillaAntarcticaAntigua and
BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia
and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei
DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman
IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling)
IslandsColombiaComorosCongoCongo (DRC)Cook IslandsCosta
RicaCroatiaCubaCyprusCzech RepublicCôte D'IvoireDenmarkDjiboutiDominicaDominican
RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland
Islands (Malvinas)Faroe IslandsFiji IslandsFinlandFranceFrench GuianaFrench
PolynesiaFrench Southern
TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuineaGuinea-BissauGuyanaHaitiHeard
Island and Mcdonald IslandsHondurasHong
KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyJamaicaJapanJordanKazakhstanKenyaKiribatiKoreaKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall
IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNetherlands
AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth
KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPanamaPapua New
GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto
RicoQatarReunionRomaniaRussiaRwandaSaint HelenaSaint Kitts and NevisSaint
LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and The GrenadinesSan
MarinoSao Tome & PrincipeSaudi ArabiaSenegalSerbia and
MontenegroSerbia-MontenegroSeychellesSierra
LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSpainSri
LankaSudanSurinameSvalbard and Jan
MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad
and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos
IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited
StatesUruguayUzbekistanVanuatuVatican CityVenezuelaViet NamVirgin IslandsVirgin
Islands, BritishWallis and FutunaWestern SamoaYemenZambiaZimbabwe

--State--AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew
HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth
DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth
DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington, D.C.West
VirginiaWisconsinWyoming


REGISTER FOR EMAIL NEWSLETTERS

Expertscape
Coronavirus Briefing
MPR Daily Dose
Register

Already have an account with one of our brands? LOG IN

Terms and Conditions | Privacy Policy





ABOUT COOKIES

When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer. More information
Accept


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms.    You can set your browser to
block or alert you about these cookies, but some parts of the site will not then
work. These cookies do not store any personally identifiable information.

 * PERFORMANCE COOKIES
   
   Always Active
   
   These cookies allow us to count visits and traffic sources so we can measure
   and improve the performance of our site. They help us to know which pages are
   the most and least popular and see how visitors move around the site.    All
   information these cookies collect is aggregated and therefore anonymous. If
   you do not allow these cookies we will not know when you have visited our
   site, and will not be able to monitor its performance.

 * FUNCTIONAL COOKIES
   
   Always Active
   
   These cookies enable the website to provide enhanced functionality and
   personalisation. They may be set by us or by third party providers whose
   services we have added to our pages.    If you do not allow these cookies
   then some or all of these services may not function properly.

DO NOT SELL PERSONAL INFORMATION

Do Not Sell Personal Information

 * TARGETING COOKIES
   
   Switch Label label
   
   These cookies may be set through our site by our advertising partners. They
   may be used by those companies to build a profile of your interests and show
   you relevant adverts on other sites.    They do not store directly personal
   information, but are based on uniquely identifying your browser and internet
   device. If you do not allow these cookies, you will experience less targeted
   advertising.


BACK BUTTON PERFORMANCE COOKIES

Vendor Search Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Reject All Confirm My Choices

ABCDEFGHIJKLMNOPQRSTUVWXYZabcdefghijklmnopqrstuvwxyz0123456789-_~

x
×



APPLYING THE SCIENCE OF HMOS: OPTIMIZING THE GUT MICROBIOME FOR IMPROVED INFANT
HEALTH AND DEVELOPMENT

CME | 0.75 Credits

Start Activity